Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up of MSC-treated vs Non-treated Participants
2024-517011-74-01Phase 4Completed
- Sponsor
- Cellcolabs
- Start
- Jan 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label trial of StromaForte (2 arms), sponsored by Cellcolabs. Started Jan 2025; status: completed.
02
Drugs
StromaForte
Beyond the preview
Go deeper on 2024-517011-74-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517011-74-01.